Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 223 publications
First-in-human study of FLT3 CAR-T cell therapy for relapsed acute myeloid leukemia.
Journal: NPJ precision oncology
Published: December 03, 2025
No BCMA? No Problem: A CD70-Targeting CAR-NK Cell Shows Promise in High-risk Myeloma.
Journal: Blood cancer discovery
Published: November 03, 2025
Human pluripotent stem cell-derived innate and adaptive immune cells for cancer immunotherapy.
Journal: Cell stem cell
Published: October 04, 2025
Optimizing In Vivo CAR T-cell Engineering for Cancer Immunotherapy.
Journal: Cancer research
Published: August 27, 2025
Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer.
Journal: Journal for immunotherapy of cancer
Published: August 22, 2025
YTHDF2: a key RNA reader and antitumor target.
Journal: Trends in immunology
Published: February 13, 2025
Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy.
Journal: Nature immunology
Published: December 14, 2024
Natural killer cell-based immunotherapy for cancer.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 12, 2024
CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors.
Journal: The Journal of clinical investigation
Published: December 06, 2024
The tumor-intrinsic role of the m6A reader YTHDF2 in regulating immune evasion.
Journal: Science immunology
Published: May 31, 2024
Last Updated: 09/26/2026